Mitotic Arrest and Apoptosis in Breast Cancer Cells Induced by Origanum majorana Extract: Upregulation of TNF-α and Downregulation of Survivin and Mutant p53

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Al Dhaheri, Yusra ^a   Eid, Ali ^a,c   AbuQamar, Synan ^a   Attoub, Samir ^a   Khasawneh, Mohammad ^a   Aiche, Ghenima ^b   Hisaindee, Soleiman ^a   Iratni, Rabah ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITÉ MOULOUD MAMMERI   (Algeria)

^c QATAR UNIVERSITY   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CELL MARKER; CYCLIN B1; GAMMA H2AX; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ORIGANUM MAJORANA EXTRACT; PROTEIN P21; PROTEIN P53; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER MORPHOLOGY; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; G2 PHASE CELL CYCLE CHECKPOINT; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; MUTANT; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MITOSIS; ORIGANUM; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84874343781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056649     Document Type: Article

References (46)

1. American Cancer Society. Cancer facts and figures (2012) Available: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-031941.pdf.Accessed 2013, Jan 30.
2. Cragg GM, Newman DJ, (2000) Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 9: 2783-2797.
3. Kaczirek K, Schindl M, Weinhausel A, Scheuba C, Passler C, et al. (2004) Cytotoxic activity of camptothecin and paclitaxel in newly established continuous human medullary thyroiod carcinoma cell lines. J Clin Endocrinol Metabol 89: 2397-240.
4. Nawab A, Yunus M, Mahdi AA, Gupta S, (2011) Evaluation of Anticancer Properties of Medicinal Plants from the Indian Sub-Continent. Molecular and Cellular Pharmacology 3: 21-29.
5. Watson WH, Cai J, Jones DP, (2000) Diet and apoptosis. Annual Review of Nutrition 20: 485-505.
6. Kuno T, Tsukamoto T, Hara A, Tanaka T, (2012) Cancer chemoprevention through the induction of apoptosis by natural compounds. Journal of Biophysical Chemistry 3: 156-173.
7. Teiten M-H, Gaascht F, Eifes S, Dicato M, Diederich M, (2010) Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5: 61-74.
8. Adams LS, Phung S, Yee N, Seeram NP, Li L, et al. (2010) Blueberry Phytochemicals Inhibit Growth and Metastatic Potential of MDA-MB-231 Breast Cancer Cells through Modulation of the Phosphatidylinositol 3-Kinase Pathway. Cancer Reseach 70: 3594-3605.
9. Gu Y-H, Leonard J, (2006) In vitro effects on proliferation, apoptosis and colony inhibition in ER-dependent and ER independent human breast cancer cells by selected mushroom species. Oncology Reports 15: 417-423.
10. Lee HS, Seo EY, Kang NE, Kimb WK, (2008) [6]-Gingerol inhibits metastasis of MDA-MB-231human breast cancer cells. Journal of Nutritional Biochemistry 19: 313-319.
11. Vàgi E, Rapavi E, Hadolin M, Vàsàrhelyiné Perédi K, Balàzs A, et al. (2005) Phenolic and triterpenoid antioxidants from Origanum majorana L. herb and extracts obtained with different solvents. Journal of Agricultural and Food Chemistry 53: 17-21.
12. Al-Harbi NO, (2011) Effect of marjoram extract treatment on the cytological and biochemical changes induced by cyclophosphamide in mice. Journal of Medicinal Plants Research 5: 5479-5485.
13. Miron TL, Plaza M, Bahrim G, Ibariez E, Herrero M, (2011) Chemical composition of biocactive pressurized extracts of Romanian aromatic plants. Journal of Chromatography A. 1218: 4918-4927.
14. Tsimogiannis D, Stavrakaki M, Oreopoulou V, (2006) Isolation and characterisation of antioxidant components from Oregano (Origanum heracleoticum). InternationalJournal of Food, Science, and Technology 41: 39-48.
15. Leeja L, Thoppil JE, (2007) Antimicrobial activity of methanol extract of Origanum majorana L. (Sweet marjoram). J. Environ. Biol. 28: 145-146.
16. El-Ashmawy IM, El-Nahas AF, Salama OM, (2005) Protective effect of volatile oil, alcoholic and aqueous extracts of Origanum majorana on lead acetate toxicity in mice. Basic Clin. Pharmacol. Toxicol. 97: 238-243.
17. El-Ashmawy IM, Amal S, Salama OM, (2007) Acute and long term safety evaluation of Origanum majorana essential oil. Alex. J. Pharm. Sci. 21: 29-35.
18. El-Ashmawy IM, Saleh A, Salama OM, (2007) Effects of marjoram volatile oil and grape seed extract on ethanol toxicity in male rats. Basic Clin. Pharmacol. Toxicol. 101: 320-327.
19. Yazdanparast R, Shahriyary L, (2008) Comparative effects of Artemisia dracunculus, Satureja hortensis and Origanum majorana on inhibition of blood platelet adhesion, aggregation and secretion. Vascul. Pharmacol. 48: 32-37.
20. Lin LT, Liu LT, Chiang LC, Lin CC, (2002) In vitro anti-hepatoma activity of fifteen natural medicines from Canada. Phytotherapy Research 16: 440-444.
21. Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, et al. (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106: 348-60.
22. Maurer M, Komina O, Wesierska-Gadek J, (2009) Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells. Ann N Y Acad Sci 1171: 250-256.
23. Choi HJ, Fukui M, Zhu BT, (2011) Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with Nocodazole. PLoS ONE 6(8): e24312 doi:10.1371/journal.pone.0024312.
24. Konopleva M, Zhao S, Xie Z, Segall H, Younes A, et al. (1999) Apoptosis. Molecules and mechanisms. Adv Exp Med Biol. 457: 217-36.
25. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME, (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254: 439-459.
26. Micheau O, Tschopp J, (2003) Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 1142: 181-90.
27. Zou H, Li Y, Liu X, Wang X, (1999) An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 274: 11549-56.
28. Gupta S, (2003) Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review). Int J Oncol. 22: 15-20.
29. Zhu H, Huang M, Yang F, Chen Y, Miao ZH, et al. (2007) R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II. Mol Cancer Ther. 6: 484-95.
30. Cai Y, Lu J, Miao Z, Lin L, Ding J, (2007) Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biol Ther. 611: 1794-9.
31. Rajendran P, Ho E, Williams DE, Dashwood RH, (2011) Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics. 3: 4 doi:10.1186/1868-7083-3-4.
32. Norbury CJ, Zhivotovsky B, (2004) DNA damage-induced apoptosis. Oncogene 23: 2797-808.
33. Ljungman M (2010) The DNA damage response-repair or despair? Environ Mol Mutagen, 51: 879-89. Review.
34. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-20.
35. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, et al. (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 40: 1117-23.
36. Chandele A, Prasad V, Jagtap JC, Shukla R, Shastry PR, (2004) Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. Neoplasia 6: 29-40.
37. Reed JC, (2001) Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 7: 314-9.
38. Vogel C, Hager C, Bastians H, (2007) Mechanisms of Mitotic Cell Death Induced by Chemotherapy-Mediated G2 Checkpoint Abrogation. Cancer Res 67: 339-345.
39. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature. 408: 307-10.
40. Selivanova G (2001) Mutant p53: the loaded gun. Curr Opin Investig Drugs, 2: 1136-41. Review.
41. Fojo T (2002) p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53. Drug Resist Updat. 55: 209-16. Review.
42. Bossi G, Lapi E, Strano S, Rinaldo C, Blandino G, et al. (2006) Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 25: 304-9.
43. Wang X, Di Pasqua AJ, Govind S, McCracken E, Hong C, et al. (2011) Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships. J Med Chem. 54: 809-16.
44. Han J, Kim S, Yang JH, Nam SJ, Lee JE, (2012) TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells. Oncol Rep. 27: 517-22.
45. Sambucetti LC, Fischer DD, Zabludoff S, Kwon PO, Chamberlin H, et al. (1999) Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem. 274: 34940-7.
46. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, et al. (2011) Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolinin human epithelioid cancer cells. Eur J Pharmacol. 651: 18-25.